Novel-and Not So Novel-Inhibitors of the Multifunctional CRM1 Protein
Chromosome Region Maintenance 1 (CRM1), also known as Exportin 1 (XPO1), is a protein that is critical for transport of proteins and RNA to the cytoplasm through the nuclear pore complex. CRM1 inhibition with small molecule inhibitors is currently being studied in many cancers, including leukemias,...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_e5bc8c6adb384b8b8cc22dcfd2c8e2cc | ||
042 | |a dc | ||
100 | 1 | 0 | |a Waitman K. Aumann |e author |
700 | 1 | 0 | |a Waitman K. Aumann |e author |
700 | 1 | 0 | |a Rafi Kazi |e author |
700 | 1 | 0 | |a Amanda M. Harrington |e author |
700 | 1 | 0 | |a Daniel S. Wechsler |e author |
700 | 1 | 0 | |a Daniel S. Wechsler |e author |
245 | 0 | 0 | |a Novel-and Not So Novel-Inhibitors of the Multifunctional CRM1 Protein |
260 | |b Frontiers Media S.A., |c 2024-08-01T00:00:00Z. | ||
500 | |a 1970-5557 | ||
500 | |a 10.3389/or.2024.1427497 | ||
520 | |a Chromosome Region Maintenance 1 (CRM1), also known as Exportin 1 (XPO1), is a protein that is critical for transport of proteins and RNA to the cytoplasm through the nuclear pore complex. CRM1 inhibition with small molecule inhibitors is currently being studied in many cancers, including leukemias, solid organ malignancies and brain tumors. We review the structure of CRM1, its role in nuclear export, the current availability of CRM1 inhibitors, and the role of CRM1 in a number of distinct cellular processes. A deeper understanding of how CRM1 functions in nuclear export as well as other cellular processes may allow for the development of additional novel CRM1 inhibitors. | ||
546 | |a EN | ||
690 | |a CRM1 | ||
690 | |a XPO1 | ||
690 | |a cancer | ||
690 | |a nuclear export | ||
690 | |a leptomycin B | ||
690 | |a Other systems of medicine | ||
690 | |a RZ201-999 | ||
690 | |a Internal medicine | ||
690 | |a RC31-1245 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Oncology Reviews, Vol 18 (2024) | |
787 | 0 | |n https://www.frontiersin.org/articles/10.3389/or.2024.1427497/full | |
787 | 0 | |n https://doaj.org/toc/1970-5557 | |
856 | 4 | 1 | |u https://doaj.org/article/e5bc8c6adb384b8b8cc22dcfd2c8e2cc |z Connect to this object online. |